GI & Liver Diseases Well Represented at AASLD 2016

BRONX, NY - November 23, 2016 - The Montefiore Einstein Division of Gastroenterology & Liver Diseases faculty were well represented at the 67th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), held November 11-15, 2016 at the John B. Hynes Veterans Memorial Convention Center, in Boston, MA.  At this year’s meeting, Dr. Namita Roy-Chowdhury was inducted as a Fellow of the American Association for the Study of Liver Diseases.
 

Posters & Presentations

1. Wang, PJ, Wang, WJ, Lescaille, Y, Murray, JW , Wolkoff, AW
   Coexpression with PDZK1 and oatp1a1 facilitates trafficking of rat oatp 1a4 to the plasma membrane.

2. Jaber FL, Bandi S, Gupta P, Tchaikovskaya T, Golden A, Rhee DB, Maslov AY, Quispe W, Gupta, S
   Blockade of TNF-α signaling improves partial hepatectomy-induced liver regeneration with multiple intra- and extra-cellular benefits for tissue regeneration microenvironment. 

3. Sharma Y, Liu J, Kristian KE, Follenzi A, Gupta S
   Hepatic copper (Cu) toxicosis and inflammation impair liver repopulation with extrahepatic donor-derived stem cells in setting of Wilson’s disease (WD).
4. Viswanathan P, Sharma Y, Bandi S, Gupta S
   Gene therapy with candidate microRNAs (miRNA) capable of regulating DNA damage response rescues mice with acetaminophen (APAP)-induced acute liver failure (ALF) and
   offers new therapeutic directions.
5. Sharma Y, Viswanathan P, Gupta S
   Identification by imaging of novel receptor expression as potential biomarker and candidate for therapeutic development in drug-induced acute liver failure.
6. Dore G, Grebely J, Altice F, Litwin AH, Dalgard O, Gane EJ, Shibolet O, Luetkemeyer A, Nahass R, Peng C, Conway B, Iser DM, Huang H, Gendrano N, Kelly MM, Hwang P, Robertson M, Wahl J, Barr E, Platt HL. HCV reinfection and injecting risk behavior following elbasvir/grazoprevir treatment in patients on opioid agonist therapy: Co-STAR three year follow-up study. *AASLD Presidential Poster of Distinction.
7. Viswanathan, P., Sharma, Y, Bandi, S, Gupta, S. 
   Hepatic DNA damage response with dysregulation of ataxia telangiectasia mutated and related signaling pathways characterizes liver injury in nonalcoholic steatohepatitis.
8. Ovchinsky N, Cunningham RM, Kogan-Liberman D, Bellemare S, Kinkhabwala M, Levy P, Jan D
   Expanding the utilization of metabolic livers for Domino transplantation: Successful Domino liver transplant from a patient with propionic academia.
9. Cholapranee A,  Leff JA, Kinkhabwala M, Litwin AH, Schwartz J, Linas BP
   Cost-effectiveness of HCV treatment among liver transplantation candidates.
10. Laraque F, Ford M, Desai P, Bresnahan MP, Litwin AH, Schwartz JM, Shukla SJ, Weiss JJ, Wyatt B, Perumalswami PV
    Comprehensive care coordination reduces disparities in access to hepatitis C care and treatment in highly complex patients.